IRIS Accounts Production v24.2.0.383 06467439 Board of Directors Board of Directors Board of Directors Board of Directors 1.10.23 30.9.24 30.9.24 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure064674392023-09-30064674392024-09-30064674392023-10-012024-09-30064674392022-09-30064674392022-10-012023-09-30064674392023-09-3006467439ns16:EnglandWales2023-10-012024-09-3006467439ns15:PoundSterling2023-10-012024-09-3006467439ns11:Director12023-10-012024-09-3006467439ns11:Director22023-10-012024-09-3006467439ns11:Director32023-10-012024-09-3006467439ns11:Director42023-10-012024-09-3006467439ns11:PrivateLimitedCompanyLtd2023-10-012024-09-3006467439ns11:SmallEntities2023-10-012024-09-3006467439ns11:AuditExempt-NoAccountantsReport2023-10-012024-09-3006467439ns11:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3006467439ns11:SmallCompaniesRegimeForAccounts2023-10-012024-09-3006467439ns11:FullAccounts2023-10-012024-09-3006467439ns11:OrdinaryShareClass12023-10-012024-09-3006467439ns11:OrdinaryShareClass22023-10-012024-09-3006467439ns11:CompanySecretary12023-10-012024-09-3006467439ns11:RegisteredOffice2023-10-012024-09-3006467439ns6:CurrentFinancialInstruments2024-09-3006467439ns6:CurrentFinancialInstruments2023-09-3006467439ns6:Non-currentFinancialInstruments2024-09-3006467439ns6:Non-currentFinancialInstruments2023-09-3006467439ns6:ShareCapital2024-09-3006467439ns6:ShareCapital2023-09-3006467439ns6:RetainedEarningsAccumulatedLosses2024-09-3006467439ns6:RetainedEarningsAccumulatedLosses2023-09-3006467439ns6:FurnitureFittings2023-10-012024-09-3006467439ns6:MotorVehicles2023-10-012024-09-3006467439ns6:ComputerEquipment2023-10-012024-09-3006467439ns6:FurnitureFittings2023-09-3006467439ns6:MotorVehicles2023-09-3006467439ns6:ComputerEquipment2023-09-3006467439ns6:FurnitureFittings2024-09-3006467439ns6:MotorVehicles2024-09-3006467439ns6:ComputerEquipment2024-09-3006467439ns6:FurnitureFittings2023-09-3006467439ns6:MotorVehicles2023-09-3006467439ns6:ComputerEquipment2023-09-3006467439ns6:WithinOneYearns6:CurrentFinancialInstruments2024-09-3006467439ns6:WithinOneYearns6:CurrentFinancialInstruments2023-09-3006467439ns6:Secured2024-09-3006467439ns6:Secured2023-09-3006467439ns11:OrdinaryShareClass12024-09-3006467439ns11:OrdinaryShareClass22024-09-30

















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2024

FOR

POOLE BAY PHARMACY LTD

POOLE BAY PHARMACY LTD (REGISTERED NUMBER: 06467439)






CONTENTS OF THE FINANCIAL STATEMENTS
For The Year Ended 30 September 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


POOLE BAY PHARMACY LTD

COMPANY INFORMATION
For The Year Ended 30 September 2024







DIRECTORS: Dr L D A Brad
Dr G A Edwards
Dr S Morgan
Dr R Schuster Bruce





SECRETARY: Dr G A Edwards





REGISTERED OFFICE: Westbourne Medical Centre
Milburn Road
Westbourne
Bournemouth
Dorset
BH4 9HJ





REGISTERED NUMBER: 06467439 (England and Wales)






POOLE BAY PHARMACY LTD (REGISTERED NUMBER: 06467439)

BALANCE SHEET
30 September 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 34,293 39,369

CURRENT ASSETS
Stocks 85,413 62,161
Debtors 5 237,882 201,304
Cash at bank and in hand 106,864 108,994
430,159 372,459
CREDITORS
Amounts falling due within one year 6 348,477 318,494
NET CURRENT ASSETS 81,682 53,965
TOTAL ASSETS LESS CURRENT
LIABILITIES

115,975

93,334

CREDITORS
Amounts falling due after more than one year 7 (37,500 ) (60,000 )

PROVISIONS FOR LIABILITIES (8,573 ) (7,480 )
NET ASSETS 69,902 25,854

CAPITAL AND RESERVES
Called up share capital 9 200 200
Retained earnings 69,702 25,654
SHAREHOLDERS' FUNDS 69,902 25,854

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 12 March 2025 and were signed on its behalf by:




Dr G A Edwards - Director Dr S Morgan - Director




Dr L D A Brad - Director Dr R Schuster Bruce - Director


POOLE BAY PHARMACY LTD (REGISTERED NUMBER: 06467439)

NOTES TO THE FINANCIAL STATEMENTS
For The Year Ended 30 September 2024

1. STATUTORY INFORMATION

Poole Bay Pharmacy Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is recognised as the right to consideration obtained through the performance of contractual obligations, net of VAT.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 10% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account.

Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured as amortised cost using the effective interest rate method, less impairment.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 20 (2023 - 20 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and Motor Computer
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1 October 2023 82,774 12,083 25,027 119,884
Additions 996 - 884 1,880
At 30 September 2024 83,770 12,083 25,911 121,764
DEPRECIATION
At 1 October 2023 62,636 1,259 16,620 80,515
Charge for year 2,056 2,706 2,194 6,956
At 30 September 2024 64,692 3,965 18,814 87,471
NET BOOK VALUE
At 30 September 2024 19,078 8,118 7,097 34,293
At 30 September 2023 20,138 10,824 8,407 39,369

POOLE BAY PHARMACY LTD (REGISTERED NUMBER: 06467439)

NOTES TO THE FINANCIAL STATEMENTS - continued
For The Year Ended 30 September 2024

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 199,832 177,398
Other debtors 38,050 23,906
237,882 201,304

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 22,500 22,500
Trade creditors 290,159 275,950
Taxation and social security 28,651 13,371
Other creditors 7,167 6,673
348,477 318,494

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Bank loans 37,500 60,000

8. SECURED DEBTS

The following secured debts are included within creditors:

2024 2023
£    £   
Bank loans 60,000 82,500

The bank borrowings are secured by way of a fixed and floating charge over the company's assets.

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary A £1 100 100
100 Ordinary B £1 100 100
200 200

10. OTHER FINANCIAL COMMITMENTS

Total commitments under operating leases amounted to £271,118 as at 30 September 2024 (2023: £293,711).